USPTO Examiner HOLMES REX R - Art Unit 3792

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
17247918CONFIGURING A CARDIAC MONITORING DEVICEDecember 2020August 2023Allow3120YesNo
17106338APPARATUS, SYSTEM AND OPERATION METHOD FOR THE TREATMENT OF FEMALE SEXUAL DYSFUNCTIONNovember 2020April 2023Allow2910NoNo
17099772VEIN THROMBOEMBOLISM (VTE) RISK ASSESSMENT SYSTEMNovember 2020June 2021Allow710NoNo
17083057HEART BEAT IDENTIFICATION AND PUMP SPEED SYNCHRONIZATIONOctober 2020March 2023Allow2810YesNo
17078955CONTACT-TYPE ENDOSCOPE SERS PROBE, AND RELATED METHODSOctober 2020October 2022Allow2300NoNo
16949044PULMONARY HEALTH ASSESSMENT SYSTEMOctober 2020March 2021Allow610YesNo
17040044MULTI-SENSOR COMPOSITE RIGHT VENTRICULAR ELECTRODE AND FUSED CARDIAC RATE ADAPTIVE PACING METHODSeptember 2020September 2023Allow3611NoNo
16995965VENTRICULAR SENSING CONTROL IN A CARDIAC PACING SYSTEMAugust 2020June 2023Allow3410NoNo
16938275MOBILE DEFIBRILLATORJuly 2020August 2021Allow1331YesNo
16938438Method and System for Determining Settings for Deep Brain StimulationJuly 2020September 2022Allow2610YesNo
16926832DIELECTRIC HEADER STRUCTURE FOR REDUCING ELECTROMAGNETIC INTERFERENCEJuly 2020March 2023Abandon3221NoNo
16959092METHOD AND MEDICAL DEVICE FOR IMPLEMENTING DUAL-CHAMBER PACING MODE WITHOUT VENTRICULAR PACINGJune 2020May 2022Allow2220NoNo
16913259CONFIGURABLE ELECTRODES AND SENSORSJune 2020May 2023Allow3521YesNo
16957125DETERMINING A WATER AND A LIPID LEVEL OF SKINJune 2020November 2022Allow2810NoNo
16957132DETERMINING A WATER OR LIPID LEVEL OF SKINJune 2020November 2022Allow2810NoNo
16956690ELECTRODE BODY AND PRODUCTION METHOD FOR ELECTRODE BODYJune 2020February 2023Abandon3210NoNo
16903895System and Method for Calculating Cardiovascular Heartbeat Information from an Electronic Audio SignalJune 2020March 2023Allow3300NoNo
16769337CUFF ELECTRODE OR OPTRODE COMPRISING SOFT EDGES AND PROCESS FOR THE PRODUCTION THEREOFJune 2020November 2021Allow1821YesNo
16872321FACILITATING ASSESSMENT OF BLOOD FLOW AND TISSUE PERFUSION USING FLUORESCENCE-MEDIATED PHOTOPLETHYSMOGRAPHYMay 2020February 2023Allow3320YesNo
16859433SUBCUTANEOUS DEVICEApril 2020June 2022Allow2510NoNo
16854206PERSONALIZED AVATAR RESPONSIVE TO USER PHYSICAL STATE AND CONTEXTApril 2020June 2022Allow2620YesNo
16854463Apparatus, Systems and Methods for Intraoperative ImagingApril 2020August 2022Allow2801YesNo
16850984DEVICE, METHOD AND APPLICATION FOR ESTABLISHING A CURRENT LOAD LEVELApril 2020July 2022Allow2740YesNo
16850923PHYSIOLOGICAL MONITORING DEVICE ATTACHMENT ASSEMBLYApril 2020February 2023Allow3400NoNo
16847838Device Providing Body Temperature Regulation and/or Therapeutic Light Directed to VasculatureApril 2020June 2022Abandon2601NoNo
16847247INTEGRATED PROBE STRUCTUREApril 2020May 2022Allow2500NoNo
16835621METHOD AND DEVICE FOR MANAGING PACING THERAPY BASED ON INTERVENTRICULAR SEPTAL ACTIVITYMarch 2020April 2022Allow2500NoNo
16835617Detection and Mapping of Phrenic Nerve by PacingMarch 2020February 2023Allow3510YesNo
16835628IMPLANTABLE SYSTEM FOR STIMULATING A HUMAN HEART OR AN ANIMAL HEARTMarch 2020December 2022Allow3221YesNo
16832063EXTRACORPOREAL-CIRCULATION BLOOD PUMP DEVICEMarch 2020April 2023Abandon3710NoNo
16822993MAXILLARY DEVICES, CONTROLLER STATION, AND METHODS OF TREATING AND/OR DIAGNOSING MEDICAL DISORDERSMarch 2020January 2023Allow3410YesNo
16813426SYSTEM AND METHOD FOR AN ELECTRICAL IMPLANT DEVICE WITH INCREASED PATIENT COMPLIANCEMarch 2020June 2022Allow2710NoNo
16809607METHODS AND DEVICES FOR TREATING ERECTILE DYSFUNCTIONMarch 2020June 2022Allow2730YesNo
16809274PERCUTANEOUS BIOPSY CAUTERIZATION DEVICE AND METHODS OF USEMarch 2020March 2023Abandon3610NoNo
16643909SYSTEMS AND METHODS FOR PREDICTING MOOD, EMOTION AND BEHAVIOR OF NON-RECUMBENT SUBJECTSMarch 2020November 2023Abandon4430NoNo
16807178Diagnosis of medical conditions using voice recordings and auscultationMarch 2020June 2022Allow2810NoNo
16805094SYSTEMS AND METHODS FOR MAPPING AND MODULATING REPOLARIZATIONFebruary 2020December 2020Allow1020NoNo
16800359TISSUE EXTRACTION DEVICES AND METHODSFebruary 2020October 2021Allow2000NoNo
16793517SKIN TREATMENT APPARATUS UTILISING INTENSE PULSED LIGHT (IPL)February 2020January 2022Allow2310YesNo
16786975SYSTEMS AND METHODS FOR SELECTING, POSITIONING, AND CONTROLLING CARDIAC RESYNCHRONIZATION THERAPY (CRT) ELECTRODESFebruary 2020October 2022Allow3221NoNo
16784758LINGUAL REPOSITIONING DEVICES, CONTROLLER STATION, AND METHODS OF TREATING AND/OR DIAGNOSING MEDICAL DISORDERSFebruary 2020January 2023Allow3610NoNo
16778058System And Method For Predicting Tissue IntegrityJanuary 2020February 2022Allow2520NoNo
16735743METHOD AND DEVICE FOR IMPROVING PREDICTION AND DETECTION OF CHANGE IN A PHYSIOLOGICAL CONDITIONJanuary 2020May 2022Allow2820YesNo
16723749STIMULATION METHODS AND APPARATUSDecember 2019November 2020Allow1010NoNo
16717566WEARABLE CARDIAC DEFIBRILLATOR (WCD) SYSTEM CONTROLLING CONDUCTIVE FLUID DEPLOYMENTDecember 2019February 2022Allow2610NoNo
16714921SYSTEM AND METHOD FOR SENSING AND DETECTION IN AN EXTRA-CARDIOVASCULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATORDecember 2019April 2022Allow2810NoNo
16714287HEART BEAT IDENTIFICATION AND PUMP SPEED SYNCHRONIZATIONDecember 2019August 2020Allow800NoNo
16696129MULTI-THRESHOLD SENSING OF CARDIAC ELECTRICAL SIGNALS IN AN EXTRACARDIOVASCULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATORNovember 2019March 2022Allow2810YesNo
16690170FIBER BRAGG GRATING MULTI-POINT PRESSURE SENSING GUIDEWIRE WITH BIREFRINGENT COMPONENTNovember 2019November 2021Allow2410NoNo
16684420MEDICAL SYSTEM AND METHOD OF USENovember 2019June 2022Allow3110NoNo
16613621SYSTEMS AND METHODS FOR MONITORING FETAL WELLBEINGNovember 2019July 2022Allow3220YesNo
16682016IMPELLER FOR USE WITH AXIAL SHAFTNovember 2019February 2022Allow2710YesNo
16682269METHODS OF MANUFACTURING AN IMPELLERNovember 2019February 2022Allow2710NoNo
16681279LEADED ELECTRICAL STIMULATION SYSTEMNovember 2019March 2022Allow2810YesNo
16680429Intelligent Health MonitoringNovember 2019January 2021Allow1530YesNo
16678391SLEEP ASSESSMENT USING A HOME SLEEP SYSTEMNovember 2019September 2022Abandon3520NoNo
16611405SUBCUTANEOUS IMPLANTABLE DEFIBRILLATOR WITH EPICARDIAL LEAD FOR RESYNCHRONIZATION THERAPYNovember 2019March 2023Abandon4020NoNo
16663023MANAGING THERAPY DELIVERY BASED ON PHYSIOLOGICAL MARKERSOctober 2019March 2022Allow2810YesNo
16659984Real Time Acoustic Dosimetry For Corneal Collagen CrosslinkingOctober 2019September 2022Abandon3500YesYes
16654970HEART SIGNAL WAVEFORM PROCESSING SYSTEM AND METHODOctober 2019July 2022Allow3360YesNo
16595160STIMULATION PROBE ASSEMBLIES AND METHODS OF USEOctober 2019April 2022Allow3020NoNo
16583999HEART PUMP DEVICE AND METHOD FOR OPERATING SAMESeptember 2019August 2022Abandon3520NoNo
16581084Systems and Methods for Managing Pain Using an Electro-Dermal PatchSeptember 2019January 2022Allow2810NoNo
16577425Fetal Heart Rate Extraction from Maternal Abdominal ECG RecordingsSeptember 2019January 2022Allow2820NoNo
16576061SPEECH PROCESSOR HEADPIECESeptember 2019December 2021Allow2710NoNo
16573737VEHICULAR ELECTROCARDIOGRAM MEASUREMENT DEVICE AND METHODSeptember 2019March 2022Abandon3010NoNo
16572106ENERGY CONVERSION MONITORING DEVICES, SYSTEMS, AND METHODSSeptember 2019April 2022Allow3110NoNo
16569236OPHTHALMIC TREATMENT DEVICE, METHOD FOR CONTROLLING OPHTHALMIC TREATMENT DEVICE, AND FUNDUS LESION TREATMENT METHODSeptember 2019March 2022Allow3020YesNo
16556894SUBCUTANEOUS DEVICEAugust 2019March 2020Allow720YesNo
16488979METHOD AND APPARATUS FOR SENDING A MESSAGE TO A SUBJECTAugust 2019September 2022Allow3720YesNo
16537210SYSTEMS AND METHODS FOR SELECTING STIMULATION PARAMETERS BY TARGETING AND STEERINGAugust 2019June 2021Allow2221YesNo
16484800SYSTEMS AND METHODS FOR MONITORING AND CONTROLLING A STATE OF A SUBJECT DURING VOLUME RESUSCITATIONAugust 2019August 2023Abandon4820NoNo
16526393SYSTEMS AND METHODS FOR TREATING CARDIAC ARRHYTHMIASJuly 2019June 2021Allow2211YesNo
16519488REDUCING ELECTROCARDIOGRAM ARTIFACTS DURING AND POST CPRJuly 2019April 2021Allow2120YesNo
16479438Devices and Methods for Determining Heart Function of a Living SubjectJuly 2019March 2022Allow3211NoNo
16517294PATIENT-INITIATED AUTOMATIC CONTROL OF NEURAL TISSUESJuly 2019February 2021Allow1920NoNo
16515783AMBULATORY VASOACTIVITY MONITORJuly 2019February 2023Allow4320YesNo
16512220CATHETER ADAPTED FOR USE WITH GUIDE WIRE FOR ACCESSING VESSELSJuly 2019March 2021Allow2010NoNo
16510912ELECTROCARDIOGRAM METHOD FOR LACTATE THRESHOLD DETECTIONJuly 2019April 2022Allow3320NoNo
16509887WEARABLE ELECTROENCEPHALOGRAPHY DEVICE AND METHODS OF USE THEREOFJuly 2019July 2021Allow2420NoNo
16505906AXIAL FLOW IMPLANTABLE MECHANICAL CIRCULATORY SUPPORT DEVICES WITH OUTLET VOLUTEJuly 2019March 2022Allow3220YesNo
16450399INDUCTIVELY RECHARGEABLE EXTERNAL ENERGY SOURCE, CHARGER, SYSTEM AND METHOD FOR A TRANSCUTANEOUS INDUCTIVE CHARGER FOR AN IMPLANTABLE MEDICAL DEVICEJune 2019December 2021Allow3010NoNo
16472432DISTURBANCES INDICATOR FOR A WEARABLE DEVICEJune 2019December 2022Allow4110NoNo
16447218APPARATUS FOR TERMINATING OR UNPINNING ROTATING ELECTRIC ACTIVITY IN A CARDIAC TISSUEJune 2019August 2021Allow2600NoNo
16426198ENHANCED BRAIN-MACHINE INTERFACES WITH NEUROMODULATIONMay 2019August 2021Allow2710NoNo
16410117METHODS AND IMPLANTABLE MEDICAL DEVICES FOR AUTOMATIC ENTRY TO AN EXPOSURE MODE OF OPERATION UPON EXPOSURE TO A MAGNETIC DISTURBANCEMay 2019December 2022Allow4331NoYes
16409731VACUUM LOSS DETECTION DURING LASER EYE SURGERYMay 2019January 2021Allow2000NoNo
16403599SPEECH PROCESSOR HEADPIECEMay 2019September 2019Allow410NoNo
16397956WEARABLE MULTIPHASIC CARDIOVERTER DEFIBRILLATOR SYSTEM AND METHODApril 2019March 2023Allow4650YesNo
16344945HAIR RESTORATION/GROWTH STIMULATION DEVICEApril 2019November 2020Abandon1910NoNo
16380325INTRA-CARDIAC MAPPING AND ABLATINGApril 2019October 2020Allow1801YesNo
16378917METHOD AND DEVICE FOR AUTOMATIC QUALITY CONTROL OF AN RR SERIES OBTAINED FROM A CARDIAC SIGNALApril 2019February 2021Allow2310YesNo
16375221HEALTH TRACKING DEVICEApril 2019November 2020Allow1910YesNo
16375598COMPREHENSIVE SECOND-LANGUAGE ACQUISITION SYSTEM LEVERAGING SLEEP NEUROMODULATION AND NEUROAUGMENTED EXECUTIVE CONTROLApril 2019November 2021Allow3221NoNo
16375593METHOD AND SYSTEM FOR IMPROVING QUALITY OF LIFE FOR THE ELDERLY THROUGH NEUROSTIMULATIONApril 2019November 2021Allow3220NoNo
16374433SYSTEM AND METHOD TO CUE SPECIFIC MEMORY RECALLS WHILE AWAKEApril 2019November 2021Allow3120NoNo
16367774APPARATUS AND METHOD FOR TREATMENT OF DRY EYESMarch 2019November 2021Allow3230NoNo
16368486INCREASING DYNAMIC RANGE OF STIMULATION CONTROLMarch 2019July 2021Allow2810YesNo
16337920PULSE CURRENT GENERATION CIRCUIT FOR NEURAL STIMULATION, CHARGE COMPENSATION CIRCUIT AND METHOD, AND IMPLANTABLE ELECTRICAL RETINA STIMULATORMarch 2019July 2021Allow2710NoNo
16351666ACOUSTIC SENSOR PLATFORM METHOD AND APPARATUS FOR PAIN MITIGATION, APNEA DETECTION, ASPIRATION DETECTION AND PATIENT COMMUNICATION IN ANESTHESIA PATIENTSMarch 2019July 2021Allow2810YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner HOLMES, REX R.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
5
Examiner Affirmed
0
(0.0%)
Examiner Reversed
5
(100.0%)
Reversal Percentile
99.7%
Higher than average

What This Means

With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
20
Allowed After Appeal Filing
9
(45.0%)
Not Allowed After Appeal Filing
11
(55.0%)
Filing Benefit Percentile
73.7%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 45.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner HOLMES, REX R - Prosecution Strategy Guide

Executive Summary

Examiner HOLMES, REX R works in Art Unit 3792 and has examined 352 patent applications in our dataset. With an allowance rate of 84.9%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 28 months.

Allowance Patterns

Examiner HOLMES, REX R's allowance rate of 84.9% places them in the 62% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by HOLMES, REX R receive 1.97 office actions before reaching final disposition. This places the examiner in the 45% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by HOLMES, REX R is 28 months. This places the examiner in the 69% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +16.8% benefit to allowance rate for applications examined by HOLMES, REX R. This interview benefit is in the 57% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 33.4% of applications are subsequently allowed. This success rate is in the 74% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 44.4% of cases where such amendments are filed. This entry rate is in the 69% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 100.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 78% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 78.3% of appeals filed. This is in the 70% percentile among all examiners. Of these withdrawals, 55.6% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 50.0% are granted (fully or in part). This grant rate is in the 47% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.3% of allowed cases (in the 54% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).

Quayle Actions: This examiner issues Ex Parte Quayle actions in 12.0% of allowed cases (in the 91% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.